A study to evaluate the safety and efficacy of tolvaptan in HF patients who undergo cardiac angiography
Phase of Trial: Phase III
Latest Information Update: 01 Feb 2013
At a glance
- Drugs Tolvaptan (Primary)
- Indications Heart failure; Kidney disorders
- Focus Therapeutic Use
- 01 Feb 2013 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan record.
- 30 Dec 2012 Planned number of patients changed from 20 to 40 as reported by University Hospital Medical Information Network - Japan record.
- 23 Oct 2012 New trial record